Acreage Holdings (CSE:ACRG.U, OTCQX:ACRGF,FWB:0VZ) was featured in an article by Bloomberg about Canopy Growth’s (TSX:WEED,NYSE:CGC) planned acquisition of the company. According to the article, one of Acreage’s shareholders has come out in favor of its sale to the Canadian cannabis company. Cresco Capital Partners LLC has been an Acreage shareholder since 2015 and believes that the company’s association with Canopy will give it a capital boost before the deal closes.

“I think at the end of the day people will take a step back and realize that the positives far outweigh the negatives on this,” said Cresco Capital Founder and Managing Partner Matt Hawkins.


Hawkins sent a letter of support to his fund’s investors on Thursday arguing that the consolidation would benefit both Acreage and the cannabis industry as a whole. He believes that despite the difference between the offer price and Acreage’s current share price, shareholders will approve the deal at the vote on June 19. The offer requires the backing of two-thirds of Acreage’s shareholders.

As part of the deal, Acreage investors will receive $300 million in cash up front, with the remainder to be paid in Canopy shares if US laws change. Acreage is allowed to issue up to 58 million subordinate voting shares before US legalization, and those shares will become Canopy stock if the deal is completed giving Acreage “a very attractive piece of paper to be utilizing in transactions,” according to Hawkins. In Canopy’s filing on Thursday, the company stated that it could waive the US legalization contingency if the New York Stock Exchange or the Toronto Stock Exchange change their listing rules.

To read the full article, click here.

Click here to connect with Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF,FSE:0VZ) for an Investor Presentation. 

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

 Numinus Wellness Inc. (” Numinus ” or the ” Company “) (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, is pleased to announce that the TSX Venture Exchange (” TSXV “) has accepted for listing the 12,683,925 warrants (the ” Warrants “) issued pursuant to the Company’s previously announced prospectus offering that closed on December 29, 2020 .

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less